Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens
Clinical trial NCT02537418 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02537418
- Sponsor
- Canadian Cancer Trials Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-16
- Primary completion
- 2018-07-20
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.